G N Sanjeeva1,2, Pooja Gujjal Chebbi3, H B Pavithra4, M Sahana4, D R Sunil Kumar5, Lalitha Hande6. 1. Department of Pediatrics, Indira Gandhi Institute of Child Health, South Hospital Complex, Dharmaram College Post, Bangalore, 560 029, Karnataka, India. sanju_gn@rediffmail.com. 2. Pediatric Center of Excellence, Indira Gandhi Institute of Child Health, South Hospital Complex, Dharmaram College Post, Bangalore, 560 029, Karnataka, India. sanju_gn@rediffmail.com. 3. Department of Pediatrics, Indira Gandhi Institute of Child Health, South Hospital Complex, Dharmaram College Post, Bangalore, 560 029, Karnataka, India. 4. Pediatric Center of Excellence, Indira Gandhi Institute of Child Health, South Hospital Complex, Dharmaram College Post, Bangalore, 560 029, Karnataka, India. 5. CST, Ministry of Health and Family Welfare, National AIDS Control Organization, Bangalore, Karnataka, India. 6. DD (ICTC/PPTCT), KSAPS, Bangalore, Karnataka, India.
Abstract
OBJECTIVES: To study the predictors of mortality and mortality rate in a clinical cohort of Children Living with Human Immunodeficiency Virus infection (CLHIV) from India. METHODS: This retrospective cohort analysis of CLHIV aged between 2 mo and 18 y registered during January 2004 through December 2014 at Pediatric Centre of Excellence (PCOE), Indira Gandhi Institute of Child Health (IGICH), was conducted using standard data collection sheet. Demographic and clinical characteristics of all eligible children were analyzed. The primary outcome measured was mortality. The authors also analyzed the cause of death and baseline parameters associated with death to study the predictors of mortality. RESULTS: Out of 1289 CLHIV registered in the PCOE during the study period, 834 (64.7 %) CLHIV, with or without antiretroviral therapy (ART) care, were included. The total time contributed by the study participants was 2872.8 child-years. The mortality rate in these children was 4.9/100 child-years. A significantly higher mortality rate of 28.2 % was found in children < 5 y, 38.6 % in children with advanced WHO clinical staging, 35.2 % among severely immunosuppressed children and 22.3 % in severely malnourished children. Tuberculosis accounted for 28 % of deaths. Univariate Cox regression analysis showed treatment status, age <5 y, baseline WHO clinical stage 3 and 4, severe immune suppression and severe malnutrition were strongly associated with mortality. CONCLUSIONS: The mortality rate in the index study cohort was 4.9/100 child-years and tuberculosis was the major cause of death. Younger age, baseline advanced clinical and immunological staging were predictors of mortality. Even though mortality was significantly higher in Pre-ART children, treatment status was not found to be an independent predictor of mortality.
OBJECTIVES: To study the predictors of mortality and mortality rate in a clinical cohort of Children Living with Human Immunodeficiency Virus infection (CLHIV) from India. METHODS: This retrospective cohort analysis of CLHIV aged between 2 mo and 18 y registered during January 2004 through December 2014 at Pediatric Centre of Excellence (PCOE), Indira Gandhi Institute of Child Health (IGICH), was conducted using standard data collection sheet. Demographic and clinical characteristics of all eligible children were analyzed. The primary outcome measured was mortality. The authors also analyzed the cause of death and baseline parameters associated with death to study the predictors of mortality. RESULTS: Out of 1289 CLHIV registered in the PCOE during the study period, 834 (64.7 %) CLHIV, with or without antiretroviral therapy (ART) care, were included. The total time contributed by the study participants was 2872.8 child-years. The mortality rate in these children was 4.9/100 child-years. A significantly higher mortality rate of 28.2 % was found in children < 5 y, 38.6 % in children with advanced WHO clinical staging, 35.2 % among severely immunosuppressed children and 22.3 % in severely malnourished children. Tuberculosis accounted for 28 % of deaths. Univariate Cox regression analysis showed treatment status, age <5 y, baseline WHO clinical stage 3 and 4, severe immune suppression and severe malnutrition were strongly associated with mortality. CONCLUSIONS: The mortality rate in the index study cohort was 4.9/100 child-years and tuberculosis was the major cause of death. Younger age, baseline advanced clinical and immunological staging were predictors of mortality. Even though mortality was significantly higher in Pre-ART children, treatment status was not found to be an independent predictor of mortality.
Authors: M-F Anaky; J Duvignac; L Wemin; A Kouakoussui; S Karcher; S Touré; C Seyler; P Fassinou; F Dabis; T N'Dri-Yoman; X Anglaret; V Leroy Journal: Bull World Health Organ Date: 2009-12-21 Impact factor: 9.408
Authors: Lukas Fenner; Martin W G Brinkhof; Olivia Keiser; Ralf Weigel; Morna Cornell; Harry Moultrie; Hans Prozesky; Karl Technau; Brian Eley; Paula Vaz; Margaret Pascoe; Janet Giddy; Gilles Van Cutsem; Robin Wood; Matthias Egger; Mary-Ann Davies Journal: J Acquir Immune Defic Syndr Date: 2010-08 Impact factor: 3.731
Authors: Eduardo Villamor; Lara Misegades; Maulidi R Fataki; Roger L Mbise; Wafaie W Fawzi Journal: Int J Epidemiol Date: 2005-01-13 Impact factor: 7.196
Authors: Dalton C Wamalwa; Elizabeth M Obimbo; Carey Farquhar; Barbra A Richardson; Dorothy A Mbori-Ngacha; Irene Inwani; Sara Benki-Nugent; Grace John-Stewart Journal: BMC Pediatr Date: 2010-05-18 Impact factor: 2.125
Authors: Elizabeth M Obimbo; Dorothy A Mbori-Ngacha; James O Ochieng; Barbra A Richardson; Phelgona A Otieno; Rose Bosire; Carey Farquhar; Julie Overbaugh; Grace C John-Stewart Journal: Pediatr Infect Dis J Date: 2004-06 Impact factor: 2.129
Authors: Ali Judd; Elizabeth Chappell; Anna Turkova; Sophie Le Coeur; Antoni Noguera-Julian; Tessa Goetghebuer; Katja Doerholt; Luisa Galli; Dasja Pajkrt; Laura Marques; Intira J Collins; Diana M Gibb; Maria Isabel González Tome; Marisa Navarro; Josiane Warszawski; Christoph Königs; Vana Spoulou; Filipa Prata; Elena Chiappini; Lars Naver; Carlo Giaquinto; Claire Thorne; Magdalena Marczynska; Liubov Okhonskaia; Klara Posfay-Barbe; Pradthana Ounchanum; Pornchai Techakunakorn; Galina Kiseleva; Ruslan Malyuta; Alla Volokha; Luminita Ene; Ruth Goodall Journal: PLoS Med Date: 2018-01-30 Impact factor: 11.069